Lives unaffected by cystic fibrosis

DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

ABBV-3067

Phase Two

Phase Two

Therapeutic Approach

Restore CFTR Function

ABBV-3067 is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell. 

Status

A phase 2 study to test the safety and effectiveness of ABBV-3067 is underway. The study will test ABBV-3067 both alone and in combination with ABBV-2222, a CFTR corrector.

Sponsor

This program is sponsored by Abbvie and is being conducted within the Therapeutics Development Network.



Contact us about ABBV-3067 >